American Society of Hematology

SHERPA: Blue

People

  1. Zelenetz
    Zelenetz
  2. O'Reilly
    O'Reilly
  3. Van Den Brink
    Van Den Brink
  4. Kernan
    Kernan
  5. Levine
    Levine
  6. Moore
    Moore
  7. Moskowitz
    Moskowitz
  8. Tallman
    Tallman
  9. Giralt
    Giralt
  10. Young
    Young

Groups

  1. Hematologic Oncology, Division of (1209)
  2. Leukemia Disease Management Team (1007)
  3. Sloan Kettering Institute Faculty (685)
  4. Leukemia Service (460)
  5. Lymphoma Disease Management Team (453)
  6. Myeloma Disease Management Team (412)
  7. Adult Bone Marrow Transplant (BMT) Service (407)
  8. Hematologic Oncology Disease Management Team (385)
  9. Lymphoma Service (364)
  10. Pediatrics, Department of (350)
Search Within
Refine Results
Formats
  1. Meeting Abstract (1514)
  2. Journal Article (610)
Groups
  1. Hematologic Oncology, Division of (1209)
  2. Leukemia Disease Management Team (1007)
  3. Sloan Kettering Institute Faculty (685)
  4. Leukemia Service (460)
  5. Lymphoma Disease Management Team (453)
  6. Myeloma Disease Management Team (412)

More Groups

People
  1. Andrew Zelenetz (171)
  2. Richard O'Reilly (162)
  3. Stephen Nimer (151)
  4. Marcel Van Den Brink (126)
  5. Nancy Kernan (124)
  6. Malcolm Moore (120)

More People

Years
  1. 2018 (5)
  2. 2017 (63)
  3. 2016 (31)
  4. 2015 (228)
  5. 2014 (230)
  6. 2013 (37)

More Years

Publications
  1. Blood (2089)
  2. Hematology-American Society of Hematology Education Program (23)
  3. Blood Advances (12)

Results (2124)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma
    Journal Article

    Horwitz, S. M.; Koch, R.; Porcu, P.; Oki, Y.; Moskowitz, A.; Perez, M.; Myskowski, P.; Officer, A.; Jaffe, J. D.; Morrow, S. N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies
    Journal Article

    Flinn, I. W.; O’Brien, S.; Kahl, B.; Patel, M.; Oki, Y.; Foss, F. F.; Porcu, P.; Jones, J.; Burger, J. A.; Jain, N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M.; Rosenblat, T.; Jurcic, J. G.; Brentjens, R. J.; Arcila, M. E.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide
    Journal Article

    McCurdy, S. R.; Zhang, M. J.; St. Martin, A.; Al Malki, M. M.; Bashey, A.; Gaballa, S.; Keesler, D. A.; Hamadani, M.; Norkin, M.; Perales, M. A.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia
    Journal Article

    Stein, E. M.; Walter, R. B.; Erba, H. P.; Fathi, A. T.; Advani, A. S.; Lancet, J. E.; Ravandi, F.; Kovacsovics, T.; DeAngelo, D. J.; Bixby, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Bone disease in monoclonal gammopathy of undetermined significance: Results from a screened population-based study
    Journal Article

    Thorsteinsdottir, S.; Lund, S. H.; Lindqvist, E. K.; Thordardottir, M.; Sigurdsson, G.; Costello, R.; Burton, D.; Steingrimsdottir, H.; Gudnason, V.; Eiriksdottir, G.; more...
    Blood Advances (2017)

    Fulltext@MSK | Save
  • VLITL is a major cross-ß-sheet signal for fibrinogen Aα-chain frameshift variants
    Journal Article

    Garnier, C.; Briki, F.; Nedelec, B.; Le Pogamp, P.; Dogan, A.; Rioux-Leclercq, N.; Goude, R.; Beugnet, C.; Martin, L.; Delpech, M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Initial Hodgkin treatment of the frail elderly
    Journal Article

    Straus, D. J.
    Blood (2017)

    Fulltext@MSK | Save
  • Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: A PIDTC natural history study
    Journal Article

    Heimall, J.; Logan, B. R.; Cowan, M. J.; Notarangelo, L. D.; Griffith, L. M.; Puck, J. M.; Kohn, D. B.; Pulsipher, M. A.; Parikh, S.; Martinez, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Empiric antibiotic use in allogeneic hematopoietic cell transplantation: Should we avoid anaerobe coverage?
    Journal Article

    Shono, Y.; van den Brink, M. R. M.
    Blood Advances (2017)

    Fulltext@MSK | Save